These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 10602420)

  • 21.
    Wang W; Li H; Huang M; Wang X; Li W; Qian X; Jing L
    Open Biol; 2022 Oct; 12(10):220172. PubMed ID: 36285442
    [No Abstract]   [Full Text] [Related]  

  • 22. The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia.
    Arabanian LS; Johansson P; Staffas A; Nilsson T; Rouhi A; Fogelstrand L; Palmqvist L
    Leuk Res; 2018 Dec; 75():61-68. PubMed ID: 30384975
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hoxa9 and Meis1 Cooperatively Induce Addiction to Syk Signaling by Suppressing miR-146a in Acute Myeloid Leukemia.
    Mohr S; Doebele C; Comoglio F; Berg T; Beck J; Bohnenberger H; Alexe G; Corso J; Ströbel P; Wachter A; Beissbarth T; Schnütgen F; Cremer A; Haetscher N; Göllner S; Rouhi A; Palmqvist L; Rieger MA; Schroeder T; Bönig H; Müller-Tidow C; Kuchenbauer F; Schütz E; Green AR; Urlaub H; Stegmaier K; Humphries RK; Serve H; Oellerich T
    Cancer Cell; 2017 Apr; 31(4):549-562.e11. PubMed ID: 28399410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of myeloid differentiation by Hoxa9, Hoxb8, and Meis homeobox genes.
    Fujino T; Yamazaki Y; Largaespada DA; Jenkins NA; Copeland NG; Hirokawa K; Nakamura T
    Exp Hematol; 2001 Jul; 29(7):856-63. PubMed ID: 11438208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HoxA9-mediated immortalization of myeloid progenitors requires functional interactions with TALE cofactors Pbx and Meis.
    Schnabel CA; Jacobs Y; Cleary ML
    Oncogene; 2000 Feb; 19(5):608-16. PubMed ID: 10698505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of a conserved family of Meis1-related homeobox genes.
    Steelman S; Moskow JJ; Muzynski K; North C; Druck T; Montgomery JC; Huebner K; Daar IO; Buchberg AM
    Genome Res; 1997 Feb; 7(2):142-56. PubMed ID: 9049632
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolated Hoxa9 overexpression predisposes to the development of lymphoid but not myeloid leukemia.
    Beachy SH; Onozawa M; Silverman D; Chung YJ; Rivera MM; Aplan PD
    Exp Hematol; 2013 Jun; 41(6):518-529.e5. PubMed ID: 23435313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HOXB6 overexpression in murine bone marrow immortalizes a myelomonocytic precursor in vitro and causes hematopoietic stem cell expansion and acute myeloid leukemia in vivo.
    Fischbach NA; Rozenfeld S; Shen W; Fong S; Chrobak D; Ginzinger D; Kogan SC; Radhakrishnan A; Le Beau MM; Largman C; Lawrence HJ
    Blood; 2005 Feb; 105(4):1456-66. PubMed ID: 15522959
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Multiplex CRISPR-Screen Identifies PLA2G4A as Prognostic Marker and Druggable Target for HOXA9 and MEIS1 Dependent AML.
    Hassan JJ; Lieske A; Dörpmund N; Klatt D; Hoffmann D; Kleppa MJ; Kustikova OS; Stahlhut M; Schwarzer A; Schambach A; Maetzig T
    Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502319
    [No Abstract]   [Full Text] [Related]  

  • 30. [Identification of proteins associated with transcription factors HOXA9 and E2A-PBX1 by tandem affinity purification].
    Shestakova EA; Boutin M; Bourassa S; Bonneil E; Bijl JJ
    Mol Biol (Mosk); 2017; 51(3):490-501. PubMed ID: 28707666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
    Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hoxa9 and Meis1 are key targets for MLL-ENL-mediated cellular immortalization.
    Zeisig BB; Milne T; García-Cuéllar MP; Schreiner S; Martin ME; Fuchs U; Borkhardt A; Chanda SK; Walker J; Soden R; Hess JL; Slany RK
    Mol Cell Biol; 2004 Jan; 24(2):617-28. PubMed ID: 14701735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-terminal domain of MEIS1 converts PKNOX1 (PREP1) into a HOXA9-collaborating oncoprotein.
    Bisaillon R; Wilhelm BT; Krosl J; Sauvageau G
    Blood; 2011 Oct; 118(17):4682-9. PubMed ID: 21900201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hoxa9 immortalizes a granulocyte-macrophage colony-stimulating factor-dependent promyelocyte capable of biphenotypic differentiation to neutrophils or macrophages, independent of enforced meis expression.
    Calvo KR; Sykes DB; Pasillas M; Kamps MP
    Mol Cell Biol; 2000 May; 20(9):3274-85. PubMed ID: 10757811
    [TBL] [Abstract][Full Text] [Related]  

  • 35. p27kip1 maintains a subset of leukemia stem cells in the quiescent state in murine MLL-leukemia.
    Zhang J; Seet CS; Sun C; Li J; You D; Volk A; Breslin P; Li X; Wei W; Qian Z; Zeleznik-Le NJ; Zhang Z; Zhang J
    Mol Oncol; 2013 Dec; 7(6):1069-82. PubMed ID: 23988911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice.
    Kroon E; Thorsteinsdottir U; Mayotte N; Nakamura T; Sauvageau G
    EMBO J; 2001 Feb; 20(3):350-61. PubMed ID: 11157742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two isoforms of HOXA9 function differently but work synergistically in human MLL-rearranged leukemia.
    He M; Chen P; Arnovitz S; Li Y; Huang H; Neilly MB; Wei M; Rowley JD; Chen J; Li Z
    Blood Cells Mol Dis; 2012 Aug; 49(2):102-6. PubMed ID: 22633751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MEIS1-mediated transactivation of synaptotagmin-like 1 promotes CXCL12/CXCR4 signaling and leukemogenesis.
    Yokoyama T; Nakatake M; Kuwata T; Couzinet A; Goitsuka R; Tsutsumi S; Aburatani H; Valk PJ; Delwel R; Nakamura T
    J Clin Invest; 2016 May; 126(5):1664-78. PubMed ID: 27018596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-Met inhibition in a HOXA9/Meis1 model of CN-AML.
    Mulgrew NM; Kettyle LM; Ramsey JM; Cull S; Smyth LJ; Mervyn DM; Bijl JJ; Thompson A
    Dev Dyn; 2014 Jan; 243(1):172-81. PubMed ID: 24307265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deregulation of the HOXA9/MEIS1 axis in acute leukemia.
    Collins CT; Hess JL
    Curr Opin Hematol; 2016 Jul; 23(4):354-61. PubMed ID: 27258906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.